J. Ostrowski

906 total citations · 1 hit paper
5 papers, 636 citations indexed

About

J. Ostrowski is a scholar working on Surgery, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, J. Ostrowski has authored 5 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in J. Ostrowski's work include Pancreatic and Hepatic Oncology Research (1 paper), Sarcoma Diagnosis and Treatment (1 paper) and Lymphadenopathy Diagnosis and Analysis (1 paper). J. Ostrowski is often cited by papers focused on Pancreatic and Hepatic Oncology Research (1 paper), Sarcoma Diagnosis and Treatment (1 paper) and Lymphadenopathy Diagnosis and Analysis (1 paper). J. Ostrowski collaborates with scholars based in United Kingdom. J. Ostrowski's co-authors include Pauline Leonard, Juan W. Valle, John P. Neoptolemos, Peter Harper, F. Adab, A. Crellin, Janet Dunn, Werner Scheithauer, Deborah Stocken and Ian Chau and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Gynecologic Oncology.

In The Last Decade

J. Ostrowski

5 papers receiving 625 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

2009 602 citations David Cunningham, Ian Chau et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by J. Ostrowski

Since Specialization

Citations

This map shows the geographic impact of J. Ostrowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ostrowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ostrowski more than expected).

Fields of papers citing papers by J. Ostrowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Ostrowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ostrowski. The network helps show where J. Ostrowski may publish in the future.

Co-authorship network of co-authors of J. Ostrowski

This figure shows the co-authorship network connecting the top 25 collaborators of J. Ostrowski. A scholar is included among the top collaborators of J. Ostrowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Ostrowski. J. Ostrowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer breakdown → 2009 ·Journal of Clinical Oncology ·David Cunningham, Ian Chau, Deborah Stocken, Juan W. Valle, David B. Smith, William P. Steward, Peter Harper, Janet Dunn, Catrin Tudur Smith, (unknown), Stephen Falk, A. Crellin, F. Adab, Joyce Thompson, Pauline Leonard, J. Ostrowski, Martin Eatock, Werner Scheithauer, Richard Herrmann, John P. Neoptolemos	602
2	A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: A study by the Scottish Gynaecological Cancer Trials Group (SGCTG) 2005 ·European Journal of Cancer ·Nicholas Reed, (unknown), Robert E. Coleman, David E. Parkin, John D. Graham, Stuart Kaye, J. Ostrowski, Ian D. Duncan, James Paul, A. Hay	12
3	Favourable IGCCCG subgroups of stage II NSGCT patients may require less chemotherapy if TNM staging is included 2004 ·Journal of Clinical Oncology ·(unknown), M. V. Williams, John Ong, J. Ostrowski, R.T.D. Oliver	2
4	Sclerotherapy with bleomycin for recurrent massive inguinal lymphoceles following partial vulvectomy and bilateral lymphadenectomy—Case report and literature review 2003 ·Gynecologic Oncology ·(unknown), B.R. Sharma, (unknown), J. Ostrowski, Joaquı́n J. Nieto	9
5	Idarubicin and cyclophosphamide—an active oral chemotherapy regimen for advanced breast cancer 2000 ·Critical Reviews in Oncology/Hematology ·Robert Leonard, David Cameron, (unknown), J. Ostrowski, Anthony Howell	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact